BECTON, DICKINSON AND COMPANY Restructuring Charges
BECTON, DICKINSON AND COMPANY (BDX) reported Restructuring Charges of $605.00 million for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:RestructuringCharges · last filed 2026-08-06
- BECTON, DICKINSON AND COMPANY restructuring charges for the quarter ending 2026-06-30 was $48.00M, a 17.24% decline year-over-year.
- BECTON, DICKINSON AND COMPANY restructuring charges for the quarter ending 2026-03-31 was $482.00M, a 665.08% increase year-over-year.
- BECTON, DICKINSON AND COMPANY restructuring charges for the quarter ending 2025-12-31 was $75.00M, a 13.64% increase year-over-year.
- BECTON, DICKINSON AND COMPANY restructuring charges for the quarter ending 2025-09-30 was $88.00M, a 29.60% decline year-over-year.
- BECTON, DICKINSON AND COMPANY restructuring charges for fiscal 2025 was $275.00M, a 28.94% decline from fiscal 2024.
- BECTON, DICKINSON AND COMPANY restructuring charges for fiscal 2024 was $387.00M, a 61.92% increase from fiscal 2023.
- BECTON, DICKINSON AND COMPANY restructuring charges for fiscal 2023 was $239.00M, a 94.31% increase from fiscal 2022.
- BECTON, DICKINSON AND COMPANY restructuring charges for fiscal 2022 was $123.00M, a 179.55% increase from fiscal 2021.
| Period end | Restructuring Charges 3 month | Restructuring Charges 6 month | Restructuring Charges 9 month | Restructuring Charges 12 month |
|---|---|---|---|---|
| 2026-06-30 | $48.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-06 | $530.00M derived: sum of 2 quarters · filed 2026-08-06 | $605.00M 10-Q · filed 2026-08-06 | $693.00M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $482.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-07 | $557.00M 10-Q · filed 2026-05-07 | $645.00M derived: sum of 3 quarters · filed 2026-05-07 | $703.00M derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | $75.00M 10-Q · filed 2026-02-09 | $163.00M derived: sum of 2 quarters · filed 2026-02-09 | $221.00M derived: sum of 3 quarters · filed 2026-02-09 | $284.00M derived: sum of 4 quarters · filed 2026-02-09 |
| 2025-09-30 | $88.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $146.00M derived: sum of 2 quarters · filed 2025-11-25 | $209.00M derived: sum of 3 quarters · filed 2025-11-25 | $275.00M 10-K · filed 2025-11-25 |
| 2025-06-30 | $58.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-08-07 | $121.00M derived: sum of 2 quarters · filed 2025-08-07 | $187.00M 10-Q · filed 2025-08-07 | $312.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2025-03-31 | $63.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-05-01 | $129.00M 10-Q · filed 2025-05-01 | $254.00M derived: sum of 3 quarters · filed 2025-11-25 | $349.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-12-31 | $66.00M 10-Q · filed 2025-02-06 | $191.00M derived: sum of 2 quarters · filed 2025-11-25 | $286.00M derived: sum of 3 quarters · filed 2025-11-25 | $384.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-09-30 | $125.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $220.00M derived: sum of 2 quarters · filed 2025-11-25 | $318.00M derived: sum of 3 quarters · filed 2025-11-25 | $387.00M 10-K · filed 2025-11-25 |
| 2024-06-30 | $95.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-01 | $193.00M derived: sum of 2 quarters · filed 2024-08-01 | $262.00M 10-Q · filed 2024-08-01 | $381.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2024-03-31 | $98.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-05-02 | $167.00M 10-Q · filed 2024-05-02 | $286.00M derived: sum of 3 quarters · filed 2025-11-25 | $347.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-12-31 | $69.00M 10-Q · filed 2024-02-01 | $188.00M derived: sum of 2 quarters · filed 2025-11-25 | $249.00M derived: sum of 3 quarters · filed 2025-11-25 | $282.00M derived: sum of 4 quarters · filed 2025-11-25 |
| 2023-09-30 | $119.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-25 | $180.00M derived: sum of 2 quarters · filed 2025-11-25 | $213.00M derived: sum of 3 quarters · filed 2025-11-25 | $239.00M 10-K · filed 2025-11-25 |
| 2023-06-30 | $61.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-08-03 | $94.00M derived: sum of 2 quarters · filed 2023-08-03 | $120.00M 10-Q · filed 2023-08-03 | $171.00M derived: sum of 4 quarters · filed 2024-11-27 |
| 2023-03-31 | $33.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-05-04 | $59.00M 10-Q · filed 2023-05-04 | $110.00M derived: sum of 3 quarters · filed 2024-11-27 | $148.00M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-12-31 | $26.00M 10-Q · filed 2023-02-02 | $77.00M derived: sum of 2 quarters · filed 2024-11-27 | $115.00M derived: sum of 3 quarters · filed 2024-11-27 | $132.00M derived: sum of 4 quarters · filed 2024-11-27 |
| 2022-09-30 | $51.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-11-27 | $89.00M derived: sum of 2 quarters · filed 2024-11-27 | $106.00M derived: sum of 3 quarters · filed 2024-11-27 | $123.00M 10-K · filed 2024-11-27 |
| 2022-06-30 | $38.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-04 | $55.00M derived: sum of 2 quarters · filed 2022-08-04 | $72.00M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $17.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-05 | $34.00M 10-Q · filed 2022-05-05 | ||
| 2021-12-31 | $17.00M 10-Q · filed 2022-02-03 | |||
| 2021-09-30 | $44.00M 10-K · filed 2023-11-21 | |||
| 2020-09-30 | $84.00M 10-K · filed 2022-11-22 | |||
| 2017-09-30 | $31.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | $39.00M derived: sum of 2 quarters · filed 2017-11-22 | $50.00M derived: sum of 3 quarters · filed 2017-11-22 | $85.00M 10-K · filed 2017-11-22 |
| 2017-06-30 | $8.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $19.00M derived: sum of 2 quarters · filed 2017-08-03 | $54.00M 10-Q · filed 2017-08-03 | $381.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2017-03-31 | $11.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-02 | $46.00M 10-Q · filed 2017-05-02 | $373.00M derived: sum of 3 quarters · filed 2017-11-22 | $423.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2016-12-31 | $35.00M 10-Q · filed 2017-02-02 | $362.00M derived: sum of 2 quarters · filed 2017-11-22 | $412.00M derived: sum of 3 quarters · filed 2017-11-22 | $476.00M derived: sum of 4 quarters · filed 2017-11-22 |
| 2016-09-30 | $327.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-22 | $377.00M derived: sum of 2 quarters · filed 2017-11-22 | $441.00M derived: sum of 3 quarters · filed 2017-11-22 | $526.00M 10-K · filed 2017-11-22 |
| 2016-06-30 | $50.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-04 | $114.00M derived: sum of 2 quarters · filed 2016-08-04 | $199.00M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $64.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-06 | $149.00M 10-Q · filed 2016-05-06 | ||
| 2015-12-31 | $85.00M 10-Q · filed 2016-02-05 | |||
| 2015-09-30 | $271.00M 10-K · filed 2017-11-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| BOSTON SCIENTIFIC CORP (BSX) | United States | $64.781B | 17.29 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |